These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33487208)

  • 1. The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19).
    Drewett GP; Smibert OC; Holmes NE; Trubiano JA
    Infect Control Hosp Epidemiol; 2022 Apr; 43(4):542-543. PubMed ID: 33487208
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?
    van Berkel M; Kox M; Frenzel T; Pickkers P; Schouten J;
    Crit Care; 2020 Oct; 24(1):600. PubMed ID: 33023606
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
    Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
    J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embracing Procalcitonin for Antimicrobial Stewardship.
    Chambliss AB
    J Appl Lab Med; 2019 Jan; 3(4):712-715. PubMed ID: 31639737
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of procalcitonin as a contribution to antimicrobial stewardship in SARS-CoV-2 infection: a retrospective cohort study.
    Williams EJ; Mair L; de Silva TI; Green DJ; House P; Cawthron K; Gillies C; Wigfull J; Parsons H; Partridge DG
    J Hosp Infect; 2021 Apr; 110():103-107. PubMed ID: 33484783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus Disease 2019 and Antibiotic Stewardship-Antibiotic Usage in Adult Patients: Is It Necessary? When Should It be Concerned?
    Önal U; Akalın H
    Balkan Med J; 2021 May; 38(3):150-155. PubMed ID: 34142958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin and Its Limitations: Why a Biomarker's Best Isn't Good Enough.
    Farooq A; Colón-Franco JM
    J Appl Lab Med; 2019 Jan; 3(4):716-719. PubMed ID: 31639738
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns.
    Schouten J; De Waele J; Lanckohr C; Koulenti D; Haddad N; Rizk N; Sjövall F; Kanj SS;
    Int J Antimicrob Agents; 2021 Oct; 58(4):106409. PubMed ID: 34339777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Procalcitonin in Diagnosis of Sepsis and Antibiotic Stewardship: Opportunities and Challenges.
    Fung AWS; Beriault D; Diamandis EP; Burnham CD; Dorman T; Downing M; Hayden J; Langford BJ
    Clin Chem; 2017 Sep; 63(9):1436-1441. PubMed ID: 28634222
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibiotic stewardship with the aid of procalcitonin].
    Amundsen EK; Moholt TK; Meyer M; Haug JB; Berild D
    Tidsskr Nor Laegeforen; 2020 Aug; 140(11):. PubMed ID: 32815338
    [No Abstract]   [Full Text] [Related]  

  • 11. Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit.
    Heesom L; Rehnberg L; Nasim-Mohi M; Jackson AIR; Celinski M; Dushianthan A; Cook P; Rivinberg W; Saeed K
    J Glob Antimicrob Resist; 2020 Sep; 22():782-784. PubMed ID: 32717489
    [No Abstract]   [Full Text] [Related]  

  • 12. Procalcitonin in patients with fever: one approach does not fit all.
    Schuetz P; Falsey AR
    Clin Microbiol Infect; 2018 Dec; 24(12):1229-1230. PubMed ID: 30076970
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the Use of Novel Biomarkers to Augment Antimicrobial Stewardship Program Activities.
    Stover KR; Kenney RM; King ST; Gross AE
    Pharmacotherapy; 2018 Feb; 38(2):271-283. PubMed ID: 29245184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital physicians' experiences with procalcitonin - implications for antimicrobial stewardship; a qualitative study.
    Christensen I; Haug JB; Berild D; Bjørnholt JV; Jelsness-Jørgensen LP
    BMC Infect Dis; 2020 Jul; 20(1):515. PubMed ID: 32677903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial stewardship in patients with confirmed coronavirus disease 2019 (COVID-19).
    Moore SE; Wilde AM; Bohn BC; Song M; Schulz P
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1698-1700. PubMed ID: 34338173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uses of Procalcitonin as a Biomarker in Critical Care Medicine.
    Maves RC; Enwezor CH
    Infect Dis Clin North Am; 2022 Dec; 36(4):897-909. PubMed ID: 36328642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to Procalcitonin Measurement in Inpatient Care: a Guide for Antibiotic Stewardship and High Value Care.
    Dronamraju V; Moffat GT; Nakeshbandi M
    J Gen Intern Med; 2020 Feb; 35(2):609-610. PubMed ID: 31342321
    [No Abstract]   [Full Text] [Related]  

  • 18. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
    Pink I; Raupach D; Fuge J; Vonberg RP; Hoeper MM; Welte T; Rademacher J
    Infection; 2021 Oct; 49(5):935-943. PubMed ID: 34021897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Stewardship and Implementation of Rapid Multiplex Respiratory Diagnostics: Is There Method in the Madness?
    Timbrook TT
    Clin Infect Dis; 2020 Oct; 71(7):1690-1692. PubMed ID: 31637437
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of procalcitonin as a tool for antibiotic stewardship.
    Murri R; Taddei E; Cauda R; Fantoni M
    Future Microbiol; 2019 Jan; 14():77-79. PubMed ID: 30644309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.